Clinical Trial Update: Proof-of Concept Study of Topical 3%-Diclofenac-Nano-Emulsion Cream for Knee OA Pain [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept trial evaluating topical 3% diclofenac nano-emulsion cream for knee osteoarthritis pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Topical diclofenac nano-emulsion cream (3%) (diclofenac)

Snippet

Sponsor: Pharmos | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED